Artículos relacionados
Área salud
[Translated article] RF – Potential Treatments for Monkeypox
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 7. (Julio - Agosto 2023)

Área salud
[Translated article] Histopathologic and Trichoscopic Correlations in Nonscarring Alopecias
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 6. (Junio 2023)
Trichoscopy is an essential tool in the evaluation of alopecia. The current compilation of trichoscopic signs in this setting helps distinguish between different forms of hair loss and has improved our understanding of the pathogenic […]

Área salud
52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience
noviembre 5, 2024
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 115. Núm. 7. (julio - agosto 2024)
Tildrakizumab is an IL-23-inhibitor that has been approved to treat plaque psoriasis. However, few reports have become available on its efficacy profile in the real-world. Our objective was to study the mid-term efficacy of tildrakizumab […]